B4GALT6 - beta-1,4-galactosyltransferase 6 Gene
Also Known as B4Gal-T6; beta4Gal-T6
Species: Homo sapiens
About B4GALT6
This gene has 5 transcripts (splice variants), 199 orthologues and 6 paralogues. Broad expression in adrenal (RPKM 5.6), brain (RPKM 4.9) and 24 other tissues.
Summary
This gene is one of seven beta-1,4-galactosyltransferase (beta4GalT) genes in human. They encode type II membrane-bound glycoproteins that appear to have exclusive specificity for the donor substrate UDP-galactose; all transfer galactose in a beta1,4 linkage to similar acceptor sugars: GlcNAc, Glc, and Xyl. Each beta4GalT has a distinct function in the biosynthesis of different glycoconjugates and saccharide structures. As type II membrane proteins, they have an N-terminal hydrophobic signal sequence that directs the protein to the Golgi apparatus and which then remains uncleaved to function as a transmembrane anchor. This gene produces multiple protein isoforms - some of which are predicted to lack the N-terminal hydrophobic signal sequence and transmembrane domain. By sequence similarity, the beta4GalTs form four groups: beta4GalT1 and beta4GalT2, beta4GalT3 and beta4GalT4, beta4GalT5 and beta4GalT6, and beta4GalT7. The canonical enzyme encoded by this gene is a lactosylceramide synthase important for glycolipid biosynthesis. [provided by RefSeq, Jan 2020]
B4GALT6 Products (4)
| mRNA | Protein | Name |
|---|---|---|
| NM_001330570.3 | NP_001317499.1 | beta-1,4-galactosyltransferase 6 isoform 2 |
| NM_001378109.1 | NP_001365038.1 | beta-1,4-galactosyltransferase 6 isoform 3 |
| NM_001378110.1 | NP_001365039.1 | beta-1,4-galactosyltransferase 6 isoform 4 |
| NM_004775.5 | NP_004766.2 | beta-1,4-galactosyltransferase 6 isoform 1 |
| Molecular Function GO Annotation | Evidence | Verweise | Source |
|---|---|---|---|
| enables UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity |
IMP
IMP: Inferred from mutant phenotype
|
24498430 | GOA |
| enables galactosyltransferase activity |
IDA
IDA: Inferred from direct assay
|
10320813 | GOA |
| enables protein binding |
IPI
IPI: Inferred from physical interaction
|
33961781 | GOA |
| Biological Process GO Annotation | Evidence | Verweise | Source |
|---|---|---|---|
| involved in lactosylceramide biosynthetic process |
IDA
IDA: Inferred from direct assay
|
10320813 | GOA |
B4GALT6 Protein Structure
Glyco_transf_7N: N-terminal region of glycosyl transferase group 7 (108 - 243)
Glyco_transf_7C: N-terminal domain of galactosyltransferase (247 - 323)
- 0
- 100
- 200
- 300
- 382 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
beta-1,4-galactosyltransferase 6 |
|
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Ehlers-Danlos Syndrome, Spondylodysplastic Type, 2 |
|
|
| Spinal Muscular Atrophy With Progressive Myoclonic Epilepsy |
|
|
| Thymus Lymphoma |
|
|
| Polycystic Kidney Disease |
|
|
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Canis familiaris | B4GALT6 | VGNC | VGNC:38354 |
| Felis catus | B4GALT6 | VGNC | VGNC:69002 |
| Rattus norvegicus | B4GALT6 | RGD | RGD:71046 |
| Macaca mulatta | B4GALT6 | VGNC | VGNC:70213 |
| Bos taurus | B4GALT6 | VGNC | VGNC:26393 |
| Mus musculus | B4GALT6 | MGD | MGI:1928380 |
| Others | B4GALT6 | NCBI |